Hepatitis Weekly articles from October 2004

Hepatitis Weekly archives from October 2004

Multiferon is an alternative for treating difficult chronic hepatitis C cases.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Multiferon is an alternative for treating difficult hepatitis C virus cases. According to recent research published in the journal Hepato - Gastroenterology, "a currently 65-year-old patient with...

Specific patient circumstances should be considered prior to liver biopsy.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Specific patient circumstances should be considered prior to liver biopsy. "Liver biopsy is traditionally the 'gold standard' for the evaluation of liver diseases. There are several situations in...

Substance abuse programs would slow HCV transmissions among homeless men.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Substance abuse programs would slow HCV transmissions among homeless men. According to recent research from the United States, "homeless individuals are at risk for numerous health problems...

Arsenic trioxide inhibits hepatitis C virus replication.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Arsenic trioxide inhibits hepatitis C virus replication. According to a study from Taiwan, "hepatitis C virus (HCV) is a serious global problem, and present therapeutics are inadequate to cure HCV...

Uncooked deer meat consumption presents a risk for hepatitis E virus infection.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Uncooked deer meat consumption presents a risk for hepatitis E virus infection. "It was reported previously food-borne transmission of hepatitis E virus (HEV) to humans from deer meat. The present...

Sevoflurane exposure is associated with a case of infant hepatitis.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Sevoflurane exposure is associated with a case of infant hepatitis. According to a report from Germany, "an 11-month-old child with primary hyperoxaluria was scheduled for a nephroureteromia...

VScan exposure increases in the Caribbean.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Medical Services International Inc. (MSITF) has begun to increase the VScan exposure in the Caribbean as a result of its early success there. The company is participating in additional regulatory...

No patterns emerge with viral breakthrough during HCV combination therapy.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- No patterns emerge with viral breakthrough during HCV combination therapy. According to recent research published in the Journal of Medical Virology, "little is known about hepatitis C virus (HCV)...

Strong association of ARK5 with tumor invasion and metastasis.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- There is a strong association of ARK5 with tumor invasion and metastasis. According to a study from Japan, "We recently identified a novel human AMPK family member, ARK5, and discovered that is a...

Leukocyte chromosomal DNA backs interferon production in Escherichia coli.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Leukocyte chromosomal DNA backs interferon production in Escherichia coli. According to a study from Iran, "interferons are cytokines that confer resistance to viral infection and inhibit cellular...

Cultivation of fetal human hepatocytes attempted in microfluidic environment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cultivation of fetal human hepatocytes was attempted in a microfluidic environment. "Various types of bioreactors composed of microstructured PDMS (Polydimethylsiloxane) layers have recently been...

Cell-specific betaC-activin expression characterized.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The cell-specific expression of betaC-activin has been characterized in rats. In a study from New Zealand, "betaC-activin expression was assessed in rat tissues, using reverse transcription and...

Antiretroviral therapy is safe for women with HCV infection.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Antiretroviral therapy is safe for women with HCV infection. "To characterize longitudinal hepatic toxicity of antiretroviral therapy in HIV-infected women with and without hepatitis C virus (HCV)...

Strategies to manage patients with viral hepatitis discussed at conference.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The world's leading hepatitis experts, along with more than 850 physicians, met for the first International Conference on the Management of Patients with Viral Hepatitis. The conference reviewed...

Fully automated test for Hepatitis A virus released.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced its second fully automated hepatitis A test in the United States for its widely used AxSYM automated immunoassay instrument system. Used to aid in the laboratory...

CCR5-Delta32 and CCR2-V641 polymorphisms not related to HCV infection response.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- CCR5-Delta32 and CCR2-V641 polymorphisms are not related to HCV infection response. Chemokine-chemokine receptor interactions are clearly "important in chronic hepatitis C virus (HCV) infection. ...

Cirrhosis and hepatocellular carcinoma increasing despite HCV infection decline.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cirrhosis and hepatocellular carcinoma are increasing in Greece, despite a decline in the incidence of HCV infection. "In this study, a comprehensive methodology for modelling the hepatitis C virus...

Dosing complete in phase 1a study of oral HCV protease inhibitor for hepatitis C.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Vertex Pharmaceuticals Incorporated (VRTX) has successfully completed the dosing portion of a phase 1a clinical trial for VX-950, an investigational oral protease inhibitor for the treatment of...

Reference laboratory network selects hepatitis C virus genotyping reagents.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Third Wave Technologies Inc. (TWTI) announced that TriCore Reference Laboratories, a laboratory network in the Southwest, has adopted Third Wave's Invader hepatitis C virus (HCV) genotyping reagents....

Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan. According to recent research from Pakistan, "transmission rates of hepatitis C virus (HCV) infection through non-sexual...

HGV transmitted efficiently via the sexual route.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Hepatitis G virus is transmitted efficiently via the sexual route. According to a study from Lebanon, "The importance of sexual transmission in the epidemiology of hepatitis G virus (HGV) and...

TGF-beta[subscript]1 may be involved in the pathogenesis of chronic liver disease.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- TGF-beta[subscript]1 may be involved in the pathogenesis of chronic liver disease. "Chronic liver disease and cirrhosis are two of the most important health problems according to current...

Biotechnology company challenges validity of Benitec's Australian patent.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., announced that it has filed with The Commissioner of Patents in Australia a request for reexamination of Benitec and Commonwealth Scientific and Industrial Research Organization's...

Investigational New Drug application filed for macular degeneration trials.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Sirna Therapeutics, Inc., (NASDAQ:RNAI) announced that the company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) to begin trials of Sirna-027 in...

Pharma company completes sale of vaccines business to ID Biomedical.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group plc (Shire) (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and ID Biomedical Corporation (ID Biomedical) (TSX: IDB; NASDAQ: IDBE) announced that they have closed the sale of Shire's...

Vaccine may be associated with increased risk of MS.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The popular hypothesis that the hepatitis B vaccine is associated with an increased risk of multiple sclerosis has been scientifically corroborated through a prospective study of patients in the United...

Hepatitis C virus NS3 helicase RNA aptamers further diagnosis and research.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus NS3 helicase RNA aptamers further diagnosis and research. According to published research from South Korea, "hepatitis C virus (HCV)-encoded nonstructural protein 3 (NS3) possesses...

Bisphenol A irreversibly inhibits some cytochrome P450 forms.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The industrial chemical bisphenol A (BPA) irreversibly inhibits the activity of some drug-metabolizing enzymes. "In order to assess the effects" of BPA "on enzymes of phase I and II...

Hepadnaviral DNA integration emerges where DNA damage is pre-existent.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Hepadnaviral DNA integration emerges where DNA damage pre-existent. According to a study from the United States, "integrated hepadnaviral DNA in livers and tumors of chronic hepatitis B patients...

C-type lectins capture and transfer hepatitis C virus infectious virions.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- C-type lectins capture and transfer hepatitis C virus infectious virions. "The molecular mechanisms involved in the hepatic tropism of hepatitis C virus (HCV) have not been identified. We have shown...

Adefovir may treat drug-resistant doubly-mutated hepatitis B infections.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Adefovir may treat drug-resistant doubly-mutated hepatitis B infections. According to a study from Germany, "during chronic hepatitis B virus (HBV) infection, mutations in the precore (PC) or basal...

Hepatitis C virus glycoproteins use CD81 to effect cell entry.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus glycoproteins use CD81 to effect cell entry. According to researchers writing in the Journal of Virology, "we recently reported that retroviral pseudotypes bearing the hepatitis...

Surveillance is mandatory after hepatocellular carcinoma and MOVC resection.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Surveillance is mandatory after hepatocellular carcinoma and MOVC resection. "We report a 54-year-old Japanese woman who developed liver tumors 102 months after hepatic resection for hepatocellular...

Hepatitis C virus activates nitric oxide synthase-mediated mutagenesis.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus activates nitric oxide synthase-mediated mutagenesis. "Hepatitis C virus (HCV) infection causes hepatitis, hepatocellular carcinoma, and B-cell lymphomas in a significant number...

Zinc triggers the assembly of hepatitis B virus capsid protein.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Zinc triggers the assembly of hepatitis B virus capsid protein. According to recent research from the United States, "assembly of virus particles in infected cells is likely to be a tightly...

Advisory board to guide development of hepatitis C prognostic products.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Exagen Diagnostics, Inc., a company focused on practical genomic markers for prognostic testing, has formed an advisory board to provide input on the company's genomic marker programs and clinical...

Nephrotic syndrome complicates hepatitis A virus infection cases.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Nephrotic syndrome complicates hepatitis A virus infection cases. "Unlike hepatitis B and C, renal involvement has been extremely uncommon in patients with hepatitis A virus (HAV) infection....

Biotech company updates progress of split flu vaccine production in China.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Sinovac Biotech Ltd. (SNVBF) announced its progress on government approval, production facility, and marketing of its proprietary split flu (influenza) vaccine. Sinovac's flu vaccine completed...

Novel alkylphosphocholines inhibit CYP-mediated enzyme activity.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A series of novel alkylphosphocholines act as potent inhibitors of CYP-mediated enzyme activity. "The inhibitory potency of four alkylphospholipids: rac-1-O-phosphocholine-2-hydroxy-octadecane...

Reported Los Angeles County AIDS cases up 89% over past 2 years.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- According to Los Angeles County's most recent "HIV/AIDS Semi-annual Surveillance Summary," the number of reported AIDS cases in Los Angeles County has skyrocketed an astonishing 89% over the past 2...

Clinical trial of patients with drug-resistant hepatitis B virus initiated.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Anadys Pharmaceuticals, Inc., (ANDS) and LG Life Sciences, Ltd., announced that the first two cohorts have completed enrollment in a phase II clinical trial of ANA380 (LB80380) in patients with...

Hepatitis study comparing Pegasys to lamivudine published in leading journal.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A study published in the New England Journal of Medicine compares Pegasys (peginterferon alfa-2a) to lamivudine, a standard of care for hepatitis B therapy in patients with hepatitis B e antigen...

Hepatitis B study establishes superior efficacy, safety of Pegasys.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- The New England Journal of Medicine published the results of a key international trial that establishes the superior efficacy and safety of Pegasys (peginterferon alfa-2a) in patients with hepatitis B...

Hepatitis B prevalent despite vaccination programs in Pacific Islands.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Prevalence of hepatitis B remains high in Pacific Island countries despite vaccination programs. "The prevalence rate of hepatitis B virus (HBV) infection in Pacific Island countries is amongst...

License agreement supports hepatitis C drug discovery program.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) has entered into a nonexclusive agreement with Chiron Corporation, granting InterMune a license to discover, develop, and commercialize small molecule therapeutic agents against...

Clinical development of interferon enhancing therapy for hepatitis C begun.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Transition Therapeutics Inc. (TTH) announced the commencement of clinical development of the company's interferon enhancer EMZ702 for the treatment of hepatitis C patients. Preclinical studies...

Liver fibrosis predicts pegIFN/ribavirin outcome in HCV coinfection.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Liver fibrosis predicts pegIFN/ribavirin outcome in HCV coinfection. "Thirty-six HIV-infected patients with chronic hepatitis C treated with peginterferon alpha-2a or 2b plus ribavirin were...

Ovine atadenovirus induces strong T cell response against hepatitis C.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice. According to recent research published in the journal Vaccine,...

Non-injecting sexual partners of HCV-infected persons at high risk for infection.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Non-injecting sexual partners of hepatitis C virus-infected persons are at high risk for acquiring HCV infection. According to a study from Scotland, "While much is known about hepatitis C virus...

Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosornal degradation.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosornal degradation. According to a study from the Netherlands, "Hepatitis C virus (HCV) is a major health problem. However, the mechanism...

Reduced CYP2E1 expression associated with poor prognosis.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Reduced expression of cytochrome P450-2E1 (CYP2E1) is a negative prognostic factor in hepatocellular carcinoma (HCC). According to researchers in China, CYP2E1 "is one of the major hepatic enzymes...

Sodium salicylate enhances liver cancer therapy in animal models.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Sodium salicylate enhances liver cancer therapy in animal models. According to published research from the Peoples Republic of China, "this study investigates the possible molecular basis leading...

Angiogenic markers are among factors that can predict liver cancer recurrence.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Angiogenic markers are among factors that can predict liver cancer recurrence. "Molecular markers (biomarkers) for hepatocellular carcinoma (HCC) metastasis and recurrence could provide additional...

Type 1 and type 2 immunity in healthy Japanese adults assessed.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Investigators have performed a serological assessment of type 1 and type 2 immunity in healthy Japanese adults. According to a study from the United States, Japan, and Costa Rica, "We assessed the...

Data presented on prevention of rejection after kidney transplantation.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Six-month data from a new European study demonstrated that cornerstone immunosuppressive therapy with Prograf (tacrolimus) in combination with sirolimus is effective for the prevention of rejection...

Comparative genomic hybridization tracks the genetics of HCV-related cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Comparative genomic hybridization tracks the genetics of HCV-related cancer. "To clarify the genetic aberrations involved in the development and progression of hepatitis C virus-associated...

Researchers report on 18-year experience of liver transplantation.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers report on adult liver transplantation at UCL in Belgium. J. Lerut and colleagues of the Catholic University of Louvain wrote, "The authors present the results of a single-center study...

Ultrasonography can predict HAT in pediatric patients.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Ultrasonography (US) can be used to identify children with a high risk of hepatic arterial thrombosis (HAT) after liver transplantation. HAT development "is a life-threatening event" in liver...

Pharma company announces addition of vice president of clinical pharmacology.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- PAREXEL International Corporation (NASDAQ:PRXL) announced the appointment of Antoni A. Piergies, MD, MSEE, as vice president, clinical pharmacology and director of PAREXEL's Clinical Pharmacology...

CYP1A2 plays key role in hepatic metabolism of trans-resveratrol.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- CYP1A2 plays a key role in hepatic trans-resveratrol metabolism. Researchers in France conducted a study "aimed at identifying the isoform(s) of human liver cytochrome P450 (CYP) involved in the...

CYP3A5 has limited role in hepatic 6beta-hydroxylation of testosterone.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- CYP3A5 has a limited role in the hepatic 6beta-hydroxylation of testosterone. According to pharmacologists in Germany, the "polymorphic expression of CYP3A5 in human livers is well established, but...

Chiron grants nonexclusive license for HCV therapeutics.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) has granted a nonexclusive license to InterMune, Inc., for the research, development, and commercialization of therapeutics against hepatitis C virus (HCV) drug targets. ...

Hepatic-like cells from embryonic stem cells isolated and differentiated.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Hepatic-like cells from embryonic stem cells have been isolated and differentiated. According to a study from Israel, "Human embryonic stem cells are pluripotent cells that can serve as a cell...

Knowledge about infectious disease status guides our bioidentity.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Knowledge about infectious disease status guides our bioidentity. "Clinical medicine and biotechnology increasingly utilize and transform human bodily tissues in novel ways. Today more and more...

Liver transplant surgeons find less rejection, better survival with drug regimen.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Transplant surgeons at Thomas Jefferson University Hospital in Philadelphia have found that a new combination of drugs results in a lower incidence of rejection in liver transplant patients than do...

Avian hepatitis B viruses depict pregenomic RNA encapsidation interactions.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Avian hepatitis B viruses depict pregenomic RNA encapsidation interactions. According to published research from the United States, "packaging of hepadnavirus pregenomic RNA (pgRNA) into capsids,...

TaqMan hepatitis C virus RNA analyte-specific reagent has wide-ranging uses.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- TaqMan hepatitis C virus RNA analyte-specific reagent has wide-ranging uses. "We determined the dynamic range, reproducibility, accuracy, genotype bias, and sensitivity of the TaqMan hepatitis C...

A new HCV beacon assay more accurately monitors chronic hepatitis C patients.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- A new HCV beacon assay more accurately monitors chronic hepatitis C patients. According to a study from the Peoples Republic of China, "levels of hepatitis B virus (HBV) DNA in the blood serve as...

Metabolite assays detect 6-mercaptopurine toxicity after liver transplantation.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Metabolite assays detect 6-mercaptopurine toxicity after liver transplantation. "Azathioprine and 6-mercaptopurine (6 MP) are commonly used as immunosuppression post-solid organ transplantation....

Antiviral therapy helps manage polyarteritis nodosa in hepatitis B patients.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Antiviral therapy helps manage polyarteritis nodosa in hepatitis B patients. "Polyarteritis nodosa (PAN) is a systemic inflammatory disease causing vasculitis of medium sized and small arteries....

Transfected liver cancer cells offer a new venue for exploring hepatitis B.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Transfected liver cancer cells offer a new venue for exploring hepatitis B. "Current in vitro models for hepatitis B virus (HBV) are based on human hepatoblastoma cell lines transfected with HBV...

The p38 signaling pathway influences the response of hepatitis C to interferon.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- The p38 signaling pathway influences the response of hepatitis C to interferon. "We studied the involvement of the p38 signaling pathway in the interferon (IFN)-alpha-mediated antiviral activity...

A gene variant raises liver cancer risk in alcoholic cirrhosis patients.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- A gene variant raises liver cancer risk in alcoholic cirrhosis patients. According to a study from France, "methylenetetrahydrofolate reductase (MTHFR), a key enzyme in folate metabolism, plays a...

KAT-681 prevents the formation of primary liver cancer in rodents.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- KAT-681 prevents the formation of primary liver cancer in rodents. "To examine the potential inhibitory effects of a novel liver-selective thyromimetic, KAT-681 (KAT), on the development of...

The COBAS AM assay is better suited for detecting low hepatitis B virus levels.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- The COBAS AM assay is better suited for detecting low hepatitis B virus levels. "The measurement of hepatitis B virus (HBV) DNA is important for the assessment of liver disease and treatment...

President of India inaugurates new biotech park.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- The President of India Dr. APJ Abdul Kalam inaugurated the Wockhardt Biotech Park, India's largest biopharmaceutical complex with six dedicated manufacturing plants at Aurangabad. The Rs....

Shipment begins of CLIA-waived AST test for monitoring drugs' liver effects.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Cholestech Corp. (CTEC) has begun shipping its second liver enzyme test, Aspartate Aminotransferase (AST). According to the company, this new product is the only AST test waived under the federal...

Genotoxic effects of N-nitrosomorpholine clarified.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- The genotoxic effects of N-nitrosomorpholine (NMOR) have been elucidated. NMOR "is a well-known hepatocarcinogen," scientists in Slovakia noted. "Since this compound is representative of the group...

The hepatitis C virus NS5B C-21 domain has multifunctional properties.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- The hepatitis C virus NS5B C-21 domain has multifunctional properties. According to published research from the United States, "the nonstructural protein NS5B of hepatitis C virus (HCV) is an...

Socio-biological parameters of pregnant, Maltese drug abusers assessed.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- A study from Malta assessed socio-biological characteristics of pregnant drug abusers in that country. According to Charles Savona-Ventura of DISCERN, Institute for Research on the Signs of the...

GB virus C viremia associated with increased quality of life in HIV infection.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- GB virus C viremia is associated with an increased quality of life in HIV infection. According to a study from Germany, "It was recently shown that GBV-C infection is associated with prolonged...

High frequency of HIV/HBV coinfection in Cote d'Ivoire.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- There is a high frequency of HIV/HBV coinfection in Cote d'Ivoire "A retrospective survey estimating the prevalence of hepatitis viruses B (HBV) and C (HCV) was conducted on samples taken in 1,002...

Nosocomial transmission of hepatitis C virus plagues Tunisian dialysis patients.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Nosocomial transmission of hepatitis C virus plagues Tunisian dialysis patients. "Hemodialyzed patients are recognized as a group at increased risk of infection with hepatitis C virus (HCV). The...

Biotechnology company names clinical advisory board.
October 18, 2004... 2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., announced the establishment of the company's clinical advisory board. "Each of these individuals are internationally recognized authorities in the fields of Hepatitis B and C...